• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

注射器服务项目中监测和评估的促进因素和障碍。

Facilitators and barriers to monitoring and evaluation at syringe service programs.

机构信息

Division of Allergy and Infectious Disease, School of Medicine, University of Washington, 325 9th Ave, Box 359777, Seattle, WA, 98195, USA.

Department of Global Health, University of Washington, Seattle, Washington, USA.

出版信息

Harm Reduct J. 2024 Aug 28;21(1):157. doi: 10.1186/s12954-024-01073-z.

DOI:10.1186/s12954-024-01073-z
PMID:39192340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11351253/
Abstract

BACKGROUND

Syringe services programs (SSPs) provide harm reduction supplies and services to people who use drugs and are often required by funders or partners to collect data from program participants. SSPs can use these data during monitoring and evaluation (M&E) to inform programmatic decision making, however little is known about facilitators and barriers to collecting and using data at SSPs.

METHODS

Using the Consolidated Framework for Implementation Research (CFIR), we conducted 12 key informant interviews with SSP staff to describe the overall landscape of data systems at SSPs, understand facilitators and barriers to data collection and use at SSPs, and generate recommendations for best practices for data collection at SSPs. We used 30 CFIR constructs to develop individual interview guides, guide data analysis, and interpret study findings.

RESULTS

Four main themes emerged from our analysis: SSP M&E systems are primarily designed to be responsive to perceived SSP client needs and preferences; SSP staffing capacity influences the likelihood of modifying M&E systems; external funding frequently forces changes to M&E systems; and strong M&E systems are often a necessary precursor for accessing funding.

CONCLUSIONS

Our findings highlight that SSPs are not resistant to data collection and M&E, but face substantial barriers to implementation, including lack of funding and disjointed data reporting requirements. There is a need to expand M&E-focused funding opportunities, harmonize quantitative indicators collected across funders, and minimize data collection to essential data points for SSPs.

摘要

背景

注射器服务项目 (SSP) 为吸毒者提供减少伤害的用品和服务,并且经常被资助者或合作伙伴要求从项目参与者那里收集数据。SSP 可以在监测和评估 (M&E) 中使用这些数据,以告知项目决策,但对于 SSP 收集和使用数据的促进因素和障碍知之甚少。

方法

我们使用实施研究综合框架 (CFIR) 对 SSP 工作人员进行了 12 次重点知情人访谈,以描述 SSP 数据系统的整体情况,了解 SSP 收集和使用数据的促进因素和障碍,并为 SSP 收集数据的最佳实践提出建议。我们使用了 30 个 CFIR 结构来制定个人访谈指南、指导数据分析和解释研究结果。

结果

我们的分析得出了四个主要主题:SSP 的 M&E 系统主要是为了响应感知到的 SSP 客户需求和偏好而设计的;SSP 的人员配备能力影响修改 M&E 系统的可能性;外部资金经常迫使 M&E 系统发生变化;强大的 M&E 系统通常是获得资金的必要前提。

结论

我们的研究结果表明,SSP 并不抵制数据收集和 M&E,但在实施方面面临着重大障碍,包括缺乏资金和数据报告要求不连贯。有必要扩大以 M&E 为重点的资金机会,协调不同资助者收集的定量指标,并将数据收集量最小化到 SSP 的基本数据点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54c1/11351253/1ee7f8515232/12954_2024_1073_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54c1/11351253/1ee7f8515232/12954_2024_1073_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54c1/11351253/1ee7f8515232/12954_2024_1073_Fig1_HTML.jpg

相似文献

1
Facilitators and barriers to monitoring and evaluation at syringe service programs.注射器服务项目中监测和评估的促进因素和障碍。
Harm Reduct J. 2024 Aug 28;21(1):157. doi: 10.1186/s12954-024-01073-z.
2
COVID-19 vaccine implementation at a syringe services program: experiences of frontline staff.在注射服务项目中实施 COVID-19 疫苗:一线工作人员的经验。
BMC Health Serv Res. 2024 Oct 19;24(1):1260. doi: 10.1186/s12913-024-11691-9.
3
Supporting syringe services programs in the initiation and scale-up of vaccine administration: findings from in-depth interviews.支持注射器服务项目在疫苗接种中的启动和扩大:来自深度访谈的发现。
Harm Reduct J. 2022 Sep 1;19(1):100. doi: 10.1186/s12954-022-00681-x.
4
Capacity for sustainment of recently established syringe service programs in Appalachian Kentucky: The central role of staff champions.阿巴拉契亚肯塔基州新建立的注射器服务项目的持续能力:员工拥护者的核心作用。
Drug Alcohol Rev. 2022 May;41(4):863-872. doi: 10.1111/dar.13436. Epub 2022 Feb 3.
5
Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation.在纽约市针具交换计划中实施丁丙诺啡服务:一项定性过程评估。
Harm Reduct J. 2022 Jul 10;19(1):75. doi: 10.1186/s12954-022-00654-0.
6
Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives.在 COVID-19 大流行期间,在减少伤害服务中让吸毒者参与的障碍:一项以注射器服务项目观点为基础的混合方法研究。
Int J Drug Policy. 2022 Nov;109:103825. doi: 10.1016/j.drugpo.2022.103825. Epub 2022 Aug 10.
7
Factors that influence enrollment in syringe services programs in rural areas: a qualitative study among program clients in Appalachian Kentucky.影响农村地区注射器服务项目参与的因素:阿巴拉契亚肯塔基州项目参与者的定性研究。
Harm Reduct J. 2021 Jun 30;18(1):68. doi: 10.1186/s12954-021-00518-z.
8
Were Needles Everywhere?: Differing Views on Syringe Waste and Disposal Associated With Needs-Based Syringe Services Programs Among Community Partners and Persons Who Inject Drugs.遍地都是针头?:基于需求的注射器服务项目中,社区合作伙伴和注射毒品者对注射器废物和处理相关的不同看法。
Subst Use Misuse. 2024;59(8):1174-1181. doi: 10.1080/10826084.2024.2330895. Epub 2024 Mar 20.
9
Perspectives of syringe services program operators in Michigan on their relationship with substance use treatment: a qualitative study.密歇根州注射器服务项目运营者对其与物质使用治疗关系的看法:一项定性研究。
Harm Reduct J. 2025 Mar 1;22(1):25. doi: 10.1186/s12954-025-01172-5.
10
"New Normal:" Opportunities and Challenges Faced by Syringe Service Programs Following the Effects of the COVID-19 Pandemic.“新常态”:新冠疫情影响下注射器服务项目面临的机遇与挑战
Subst Use Misuse. 2025;60(5):669-676. doi: 10.1080/10826084.2024.2447411. Epub 2025 Jan 14.

本文引用的文献

1
The updated Consolidated Framework for Implementation Research based on user feedback.基于用户反馈的更新的实施研究综合框架。
Implement Sci. 2022 Oct 29;17(1):75. doi: 10.1186/s13012-022-01245-0.
2
A systematic review of evidence-based practice implementation in drug and alcohol settings: applying the consolidated framework for implementation research framework.基于证据的实践在药物和酒精环境中的实施的系统评价:应用实施研究框架的综合框架。
Implement Sci. 2021 Mar 4;16(1):22. doi: 10.1186/s13012-021-01090-7.
3
Overdose Education and Naloxone Distribution Within Syringe Service Programs - United States, 2019.
2019 年美国在注射器具服务项目中开展过量用药教育和纳洛酮分发工作。
MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1117-1121. doi: 10.15585/mmwr.mm6933a2.
4
State Laws Governing Syringe Services Programs and Participant Syringe Possession, 2014-2019.2014 - 2019年管理注射器服务项目及参与者注射器持有情况的州法律
Public Health Rep. 2020 Jul/Aug;135(1_suppl):128S-137S. doi: 10.1177/0033354920921817.
5
Providing reproductive health services for women who inject drugs: a pilot program.为注射吸毒妇女提供生殖健康服务:一个试点项目。
Harm Reduct J. 2020 Jul 14;17(1):47. doi: 10.1186/s12954-020-00395-y.
6
Impacts of mandated data collection on syringe distribution programs in the United States.强制数据收集对美国注射器分发项目的影响。
Int J Drug Policy. 2020 Apr 4;79:102725. doi: 10.1016/j.drugpo.2020.102725.
7
Stakeholder Perspectives on Implementation Challenges and Strategies for Moving On Initiatives in Permanent Supportive Housing.利益相关者对永久性支持性住房中推行“On”计划的实施挑战和策略的观点。
J Behav Health Serv Res. 2020 Jul;47(3):346-364. doi: 10.1007/s11414-019-09680-6.
8
CFIR simplified: Pragmatic application of and adaptations to the Consolidated Framework for Implementation Research (CFIR) for evaluation of a patient-centered care transformation within a learning health system.简化版CFIR:将实施研究综合框架(CFIR)实际应用于并调整以评估学习型健康系统中以患者为中心的护理转型。
Learn Health Syst. 2019 Sep 26;4(1):e10201. doi: 10.1002/lrh2.10201. eCollection 2020.
9
Using the Consolidated Framework for Implementation Research to examine implementation determinants of specialty mental health probation.运用实施研究综合框架来审视专科心理健康缓刑的实施决定因素。
Health Justice. 2019 Dec 5;7(1):17. doi: 10.1186/s40352-019-0098-5.
10
Attitudes of primary care physicians toward prescribing buprenorphine: a narrative review.基层医疗机构医生开具丁丙诺啡处方的态度:叙事性综述。
BMC Fam Pract. 2019 Nov 15;20(1):157. doi: 10.1186/s12875-019-1047-z.